1. Home
  2. RFL vs CNVS Comparison

RFL vs CNVS Comparison

Compare RFL & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • CNVS
  • Stock Information
  • Founded
  • RFL 2017
  • CNVS 2000
  • Country
  • RFL United States
  • CNVS United States
  • Employees
  • RFL N/A
  • CNVS N/A
  • Industry
  • RFL Real Estate
  • CNVS Consumer Electronics/Video Chains
  • Sector
  • RFL Finance
  • CNVS Consumer Discretionary
  • Exchange
  • RFL Nasdaq
  • CNVS Nasdaq
  • Market Cap
  • RFL 55.3M
  • CNVS 57.8M
  • IPO Year
  • RFL N/A
  • CNVS 2003
  • Fundamental
  • Price
  • RFL $1.84
  • CNVS $3.31
  • Analyst Decision
  • RFL
  • CNVS Buy
  • Analyst Count
  • RFL 0
  • CNVS 1
  • Target Price
  • RFL N/A
  • CNVS $10.00
  • AVG Volume (30 Days)
  • RFL 25.8K
  • CNVS 251.1K
  • Earning Date
  • RFL 12-27-2024
  • CNVS 02-12-2025
  • Dividend Yield
  • RFL N/A
  • CNVS N/A
  • EPS Growth
  • RFL N/A
  • CNVS N/A
  • EPS
  • RFL N/A
  • CNVS N/A
  • Revenue
  • RFL $697,000.00
  • CNVS $45,005,000.00
  • Revenue This Year
  • RFL N/A
  • CNVS $50.96
  • Revenue Next Year
  • RFL N/A
  • CNVS N/A
  • P/E Ratio
  • RFL N/A
  • CNVS N/A
  • Revenue Growth
  • RFL 151.62
  • CNVS N/A
  • 52 Week Low
  • RFL $1.29
  • CNVS $0.72
  • 52 Week High
  • RFL $2.50
  • CNVS $4.19
  • Technical
  • Relative Strength Index (RSI)
  • RFL 45.87
  • CNVS 50.34
  • Support Level
  • RFL $1.74
  • CNVS $3.32
  • Resistance Level
  • RFL $1.92
  • CNVS $4.04
  • Average True Range (ATR)
  • RFL 0.09
  • CNVS 0.28
  • MACD
  • RFL -0.00
  • CNVS -0.10
  • Stochastic Oscillator
  • RFL 40.91
  • CNVS 16.03

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).

Share on Social Networks: